Seegene Unveils Groundbreaking Unattended PCR Automation, Poised to Revolutionize Global Diagnostics
Seoul, South Korea – July 24, 2025 – Seegene Inc., a leading innovator in molecular diagnostics, has today announced a momentous achievement with the unveiling of the world’s first fully unattended Polymerase Chain Reaction (PCR) automation system. This pioneering technology, showcased at the prestigious ADLM 2025 conference, is set to ignite a transformative shift in the global diagnostic landscape.
The new system represents a significant leap forward in laboratory efficiency and accessibility, addressing critical challenges faced by diagnostic facilities worldwide. By automating the entire PCR workflow – from sample loading and preparation to amplification and result analysis – without the need for continuous human intervention, Seegene’s innovation promises to dramatically increase throughput, reduce turnaround times, and minimize the risk of human error.
This unattended automation is particularly significant in the context of public health and infectious disease surveillance. The ability to process a high volume of samples reliably and efficiently, around the clock, will be instrumental in responding to emerging health threats and ensuring timely diagnoses. This advancement has the potential to democratize access to advanced molecular diagnostics, extending its reach to areas with limited laboratory resources or specialized personnel.
“We are incredibly proud to introduce a technology that we believe will fundamentally redefine molecular diagnostics,” said Dr. Jong-Yoon Chun, CEO of Seegene. “Our vision has always been to make advanced diagnostic capabilities more accessible and efficient for everyone. This unattended PCR automation is a testament to that commitment, offering unprecedented levels of autonomy and reliability that will empower laboratories and improve patient care on a global scale.”
The system’s design focuses on seamless integration into existing laboratory infrastructures while offering a robust and scalable solution. Its unattended nature allows laboratory professionals to redirect their expertise towards more complex tasks and critical decision-making, thereby optimizing the utilization of skilled personnel. Furthermore, the enhanced efficiency and reduced labor costs associated with this automation are expected to make sophisticated molecular testing more affordable and widely available.
The introduction of this technology at ADLM 2025, a premier event for laboratory medicine professionals, underscores Seegene’s position at the forefront of diagnostic innovation. Early feedback from industry experts and potential users has been overwhelmingly positive, highlighting the transformative potential of this unattended PCR automation.
Seegene anticipates that this breakthrough will not only enhance the capacity of diagnostic laboratories but also pave the way for new diagnostic applications and methodologies that were previously unfeasible. The company is committed to ongoing research and development to further refine and expand the capabilities of this revolutionary system, ensuring it continues to meet the evolving needs of global healthcare.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025’ at 2025-07-24 10:02. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.